| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $242.1M | -10.4% |
| Cost of Revenue | $191.2M | -0.8% |
| Gross Profit | $50.8M | -34.3% |
| R&D Expense | $53.8M | -1.9% |
| SG&A Expense | $48.3M | -8.4% |
| Operating Income | -$55.1M | -82.4% |
| Pre-tax Income | -$54.2M | -80.5% |
| Income Tax | $344K | +191.7% |
| Net Income | -$54.6M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $57.8M | -60.5% |
| Accounts Receivable | $37.9M | -8.8% |
| Inventory | $67.6M | -8.3% |
| Current Assets | $230.8M | -16.8% |
| Total Assets | $329.2M | -11.9% |
| Current Liabilities | $34.5M | -24.6% |
| Total Liabilities | $58.4M | -18.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$14.5M | -95.4% |
| Capital Expenditures | $21.4M | +10.7% |
| Investing Cash Flow | -$72.4M | -231.2% |
| Financing Cash Flow | -$1.3M | -101.8% |
| Free Cash Flow | -$35.9M | -34.3% |
| -84.0% |
| EPS (Basic) | -$1.23 | -75.7% |
| EPS (Diluted) | -$1.23 | -75.7% |
| Stockholders' Equity |
| $270.8M |
| -10.4% |